Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 40
Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 121
Financial Buyers Roared into Health Care Deals in Q2:18
Financial buyers, which include real estate investment trusts (REITSs) and private equity firms, are not the dominant players in the health care M&A market, although REITs have been moving into the Hospital sector in recent years. Middle-market private equity firms have had a hard time getting into and then winning auctions for healthcare entities in recent years, as strategic buyers and even some global private equity firms have outspent or even pre-empted auctions. Financial Buyers Q2:17 Q3:17 Q4:17 Q1:18 Q2:18 Deals announced 77 82 79 84 110 Share of deal volume 20% 21% 20% 20% 24% Dollars committed* $31,021 $6,229 $2,276 $3,056 $25,821 Share of dollars spent 32% 14% 2% 3% 18% * =... Read More »
LifePoint Health Goes Private with Apollo Global Management
More for-profit hospitals are landing in the hands of private equity firms. On July 23, LifePoint Health, Inc. (NASDAQ: LPNT) announced its acquisition by private equity firm Apollo Global Management (NYSE: APO) for $5.6 billion. It will be merged with Apollo’s portfolio company, RCCH HealthCare Partners. The deal takes LifePoint Health private, although the combined company will operate under the LifePoint Health name and will be led by LifePoint’s current chairman and CEO, William F. Carpenter III. The combined company will have 84 non-urban hospitals in 30 states, pro forma 2017 revenues of more than $8 billion, as well as 7,000 affiliated physicians, approximately 60,000... Read More »
Health Care M&A Deals, Week Ending July 27, 2018
The Health Care M&A Weekly chart is a selection of transactions announced during the prior week(s). The deals presented here are from our Deal Search Online database, which is updated every business day. in the quarterly report. Visit www.dealsearchonline.com to see how Deal Search Online can help you stay up-to-date on the healthcare market overall, or in a particular sector of interest to your firm. Biotechnology Acquirer Target Price Biogen Inc. Collaboration on antisense drug candidates $1.0 billion Sangamo Therapeutics, Inc. TxCell S.A. $179 million Eli Lilly and Company Exclusive collaboration on protein targets $44 million Biogen Inc. ALG-801 and ALG-802 $27.5 million Nabriva... Read More »
PE Firms Go in Big for Dental Deals
Buying dental practices has been a competitive sport for a few years now, especially among private equity firms. Eighteen deals for dental practices have been announced through July 20 this year (no prices, of course). In all of 2017, 30 deals for dental practices were announced, with the buyers either private equity firms getting in on the action, or making add-on acquisitions. Last year’s consolidations have become large platforms today. One example is Western Dental Group, a portfolio company of New Mountain Capital since 2012, which has been cobbling together a California base focused on pediatric and family dental practices. In 2017, Western Dental added 14 Smile Wide offices... Read More »
Health Care M&A Deals, Week Ending July 20, 2018
The Health Care M&A Weekly chart is a selection of transactions announced during the prior week(s). The deals presented here are from our Deal Search Online database, which is updated every business day. in the quarterly report. Visit www.dealsearchonline.com to see how Deal Search Online can help you stay up-to-date on the healthcare market overall, or in a particular sector of interest to your firm. Behavioral Health Care Acquirer Target Price Pyramid Healthcare, Inc. WaldenSierra N/A Refresh Mental Health Fairhaven Treatment Center N/A Delphi Behavioral Health Group Family Recovery Specialists N/A DayMark Recovery Services 2 behavioral health agencies N/A Biotechnology Acquirer... Read More »
Boston Scientific Buys Claret Medical
The deals keep coming from Boston Scientific Corp. (NYSE: BSX). The medical device maker announced its sixth deal so far this year on July 20. The latest target is privately held Claret Medical, Inc., based in Santa Rosa, California. Claret developed and commercialized the Sentinel Cerebral Embolic Protection System, which is used to protect the brain during certain interventional procedures, primarily during transcatheter aortic valve (TAV) replacement. It is the only device to protect patients against the risk of stroke. The Sentinel System received CE Mark in 2014 and FDA clearance in 2017. Boston Scientific agreed to pay $220 million in cash, as well as a potential reimbursement-based... Read More »
Physician Practices Kept Consolidating in Q2:18
Investor interest in physician medical groups ramped up significantly in 2018, with 55 transactions announced in the first quarter, followed by 53 deals in the second quarter. The second quarter deals represent 29% of the total of 184 announced in the previous 12 months. Deal volume slipped 4% compared with the previous quarter but posted a 61% increase versus the same quarter a year earlier. Physicians in small practices have been under growing pressure from regulations and legislation, changes in reimbursement cycles and episodes of care. Under MACRA, they may be the lead provider when it comes to bundled payments, which makes primary care and hospital-based physicians of interest to... Read More »
Healthcare Deal Volume Rose 8% in Q2:18
With 462 deals announced in the second quarter, healthcare deal volume was up 8% compared with the 427 transactions announced in the previous quarter, according to our Deal Search Online database. Deal volume was higher than the same quarter in 2017, up 21%% compared with the 383 deals reported then. Healthcare deal volume in the last two quarters has grown stronger, with both quarters in 2018 rising above 425 deals. Heavy deal volume has become the “new normal,” and judging by the most recent five quarters, the lower range begins around 380 transactions per quarter. Deal volume in the health care services category, at 285 transactions, was up 4% from the previous quarter. Services deals... Read More »
Health Care M&A Deals, Week Ending July 13, 2018
We hope you are enjoying your membership to HealthCareMandA.com. This Health Care M&A Weekly chart below is a selection of transactions announced during the prior week(s). The deals presented here are further elaborated in the monthly newsletter, Health Care M&A News, and in the quarterly report. This information also appears in our online database, Deal Search Online. Visit www.dealsearchonline.com to open a guest account and begin your search. Behavioral Health Care Acquirer Target Price Civitas Solutions, Inc. Creative Connections, Inc. n/a Biotechnology Acquirer Target Price Biodesix, Inc. Integrated Diagnostics, Inc. n/a Axovant Sciences Ltd. Global rights to BB-301 $10... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
